NG
Northstar Group Portfolio holdings
AUM
$648M
This Quarter Return
+1.71%
1 Year Return
+15.46%
3 Year Return
+67.92%
5 Year Return
+114.96%
10 Year Return
+255.05%
AUM
$597M
AUM Growth
+$597M
(+4%)
Cap. Flow
+$21.8M
Cap. Flow
% of AUM
3.66%
Top 10 Holdings %
Top 10 Hldgs %
59.26%
Holding
163
New
6
Increased
67
Reduced
31
Closed
8
Top Buys
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$681K |
| 2 |
IBHD
iShares iBonds 2024 Term High Yield and Income ETF
IBHD
|
$489K |
| 3 |
Intel
INTC
|
$399K |
| 4 |
Amazon
AMZN
|
$296K |
| 5 |
Exact Sciences
EXAS
|
$294K |
Sector Composition
| 1 | Financials | 23.73% |
| 2 | Technology | 10.67% |
| 3 | Communication Services | 8.71% |
| 4 | Consumer Discretionary | 6.91% |
| 5 | Consumer Staples | 6.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
iShares Select Dividend ETF
DVY
$20.8B
| $410K | 0.07% |
3,126
| – | – |
|
102
Pfizer
PFE
$141B
| $405K | 0.07% |
15,276
+2,050
| +15% | +$54.4K |
|
103
Industrial Select Sector SPDR Fund
XLI
$23.3B
| $395K | 0.07% |
2,999
| – | – |
|
104
Bank of New York Mellon
BK
$74.5B
| $390K | 0.07% |
5,073
+99
| +2% | +$7.61K |
|
105
Amgen
AMGN
$155B
| $378K | 0.06% |
1,452
+17
| +1% | +$4.43K |
|
106
SPDR Portfolio S&P 500 ETF
SPLG
$83.6B
| $372K | 0.06% |
5,400
| – | – |
|
107
Alibaba
BABA
$322B
| $369K | 0.06% |
4,350
+193
| +5% | +$16.4K |
|
108
AstraZeneca
AZN
$248B
| $365K | 0.06% |
5,566
| – | – |
|
109
Hershey
HSY
$37.3B
| $361K | 0.06% |
2,132
-107
| -5% | -$18.1K |
|
110
Becton Dickinson
BDX
$55.3B
| $360K | 0.06% |
1,586
-100
| -6% | -$22.7K |
|
111
Vanguard International Dividend Appreciation ETF
VIGI
$8.43B
| $343K | 0.06% |
4,284
+1,228
| +40% | +$98.2K |
|
112
FedEx
FDX
$54.5B
| $340K | 0.06% |
1,210
| – | – |
|
113
GE Vernova
GEV
$167B
| $320K | 0.05% |
973
| – | – |
|
114
Verizon
VZ
$186B
| $315K | 0.05% |
7,868
+231
| +3% | +$9.24K |
|
115
Thermo Fisher Scientific
TMO
$186B
| $314K | 0.05% |
603
| – | – |
|
116
UnitedHealth
UNH
$281B
| $301K | 0.05% |
596
+13
| +2% | +$6.58K |
|
117
Bristol-Myers Squibb
BMY
$96B
| $301K | 0.05% |
5,324
-500
| -9% | -$28.3K |
|
118
Golub Capital BDC
GBDC
$3.97B
| $300K | 0.05% |
19,788
| – | – |
|
119
Kenvue
KVUE
$39.7B
| $294K | 0.05% |
13,781
-325
| -2% | -$6.94K |
|
120
Cigna
CI
$80.3B
| $290K | 0.05% |
1,050
| – | – |
|
121
Comcast
CMCSA
$125B
| $284K | 0.05% |
7,575
+403
| +6% | +$15.1K |
|
122
Invesco NASDAQ 100 ETF
QQQM
$58.8B
| $283K | 0.05% |
1,347
| – | – |
|
123
Accenture
ACN
$162B
| $281K | 0.05% |
799
| – | – |
|
124
iShares Biotechnology ETF
IBB
$5.6B
| $280K | 0.05% |
2,118
-100
| -5% | -$13.2K |
|
125
D.R. Horton
DHI
$50.5B
| $278K | 0.05% |
1,988
| – | – |
|